Lyell Immunopharma (LYEL) has an average rating of overweight and mean price target of $37.88, according to analysts polled by FactSet.
What else is happening in Research?
Research
Oppenheimer Upgrades Entegris to Outperform From Perform, Adjusts Price Target to $180 From $160
Entegris (ENTG) has an average rating of overweight and mean price target of $167.70, according to analysts polled by FactSet.
$ENTG
Research
ABG Sundal Collier Upgrades Pandora to Buy, Boosts PT
ABG Sundal Collier on Wednesday upgraded Danish jewelry maker Pandora (PNDORA.CO) to buy from hold and raised its price target to 1000.00 Danish kroner from 610.00 kroner.
$PNDORA.CO
Research
Peel Hunt Upgrades Supermarket Income REIT to Buy, Raises PT
Peel Hunt on Wednesday upgraded British real estate investment trust Supermarket Income REIT (SUPR.L) to buy from add and increased its price target to 1.00 pound sterling from 0.9 pound.
$SUPR.L